ArticleBlood cancer journal2023

Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis.

Rajshekhar Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.